EP3331550
COMPOSITION FOR TREATING MYELOPROLIFERATIVE DISORDERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
4.8.2016:
2.11.2022:
16833893.7
:
3.8.2036
:
COMPOSITION FOR TREATING MYELOPROLIFERATIVE DISORDERS
4.8.2016
2.11.2022
:
Acceleron Pharma Inc.:
128 Sidney Street, Cambridge, MA 02139, US
:
KUMAR, Ravindra:
Acton, MA 01720, US
:
SURAGANI, Naga, Venkata Sai Rajasekhar:
Wrentham, MA 02093, US
:
201562201058 P:
4.8.2015:
US
:
201562263603 P:
4.12.2015:
US
:
US2016045631:
4.8.2016
:
A61K 38/17, C07K 14/735, C07K 14/71, C07K 19/00, A61P 35/00, A61P 19/00